• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN 4; INSULIN DELIVERY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN 4; INSULIN DELIVERY DEVICE Back to Search Results
Model Number N/A
Device Problems Inaccurate Delivery (2339); Infusion or Flow Problem (2964); Unintended Movement (3026)
Patient Problem Hypoglycemia (1912)
Event Date 10/01/2018
Event Type  Injury  
Event Description
Event verbatim [preferred term] (related symptoms if any separated by commas): severe hypoglycaemia [hypoglycaemia].Hypoglycaemia and patient took 1 hour to get back to consciousness [hypoglycaemic unconsciousness].Pen is not delivering correct units [incorrect dose administered by device] it operates in jerks [device issue].Case description: this serious spontaneous case from (b)(6) was reported by a consumer as "severe hypoglycaemia" with an unspecified onset date, "hypoglycaemia and patient took 1 hour to get back to consciousness" with an unspecified onset date, "pen is not delivering correct units" with an unspecified onset date, "it operates in jerks" with an unspecified onset date, and concerned a female patient who was treated with novopen 4 (insulin delivery device) from unknown start date due to "device therapy".Patient's height, weight and body mass index were not reported.Medical history included type 1 diabetes mellitus (b)(6).On an unknown date patient experienced severe hypoglycaemia during use of novopen 4.It was reported that the emergency doctor needed 1 hour to get patient back to consciousness.It was also reported that pen was not delivering correct units and it operates in jerks.Batch number available.The outcome for the event "severe hypoglycaemia" was not reported.The outcome for the event "hypoglycaemia and patient took 1 hour to get back to consciousness" was not reported.The outcome for the event "pen is not delivering correct units" was not reported.The outcome for the event "it operates in jerks" was not reported.
 
Event Description
Severe hypoglycaemia [hypoglycaemia].Hypoglycaemia and patient took 1 hour to get back to consciousness [hypoglycaemic unconsciousness].Pen is not delivering correct units [incorrect dose administered by device].It operates in jerks, the units are difficult to dial plus correct to dial, it is like a cogwheel [device issue].Use of dialling clicks to estimate the dose of the insulin [wrong technique in device usage process].Case description: this serious spontaneous case from germany was reported by a consumer as "severe hypoglycaemia" beginning on oct-2018, "hypoglycaemia and patient took 1 hour to get back to consciousness" beginning on oct-2018, "pen is not delivering correct units" beginning on oct-2018, "it operates in jerks, the units are difficult to dial plus correct to dial, it is like a cogwheel" beginning on oct-2018, "use of dialling clicks to estimate the dose of the insulin" beginning on unspecifed date, and concerned a 30 years old female patient who was treated with novopen 4 (insulin delivery device) from unknown start date to mar-2019 due to "type 1 diabetes mellitus", patient's height: 174 cm, patient's weight: 55 kg, patient's bmi: 18.1660.Concomitant products included - novorapid (insulin aspart) solution for injection, 100 u/ml.On an unspecified date in oct-2018, the patient experienced severe hypoglycaemia during use of novopen 4.It was reported that once the emergency doctor needed 1 hour to get patient back to consciousness.On an unspecified date in oct-2018, the pen was not delivering correct units and it operates in jerks.The units were difficult to dial and correct to dial, it was like a cogwheel.Due to not setting correct units there was too much insulin which resulted in severe hypoglycaemia and patient was hospitalized in intensive care unit.It was reported that the patient was using dialing clicks to estimate the dose of insulin and became unsure of the number of units delivered.The patient measured blood glucose before injecting additional units.It was reported that insulin in use was stored at room temperature 20 - 25 degree celsius and there was no change in diet or physical activity of the patient.The patient was trained by a hcp (health care professional) in the use of novopen 4.Action taken to novopen 4 was product discontinued due to ae (adverse event).The outcome for the event "severe hypoglycaemia" was not yet recovered.The outcome for the event "hypoglycaemia and patient took 1 hour to get back to consciousness" was not reported.The outcome for the event "pen is not delivering correct units" was not reported.The outcome for the event "it operates in jerks, the units are difficult to dial plus correct to dial, it is like a cogwheel" was not reported.The outcome for the event "use of dialling clicks to estimate the dose of the insulin" was not reported.Investigational results: product: novopen 4.Batch number: aug1069.Visual and functional examinations were performed.The device was tested with a random cartridge and a novo nordisk needle was mounted.During testing it was possible to deliver preparation from the cartridge.The force required to depress the release-button was measured.The result was within acceptable limits.The dose accuracy was measured by weighing using a random penfill cartridge.The results were found to comply with specifications.The device was disassembled to examine internal parts.Foreign matter was observed inside the pen mechanism and under the dose button.The top of the dose button cannot rotate as normal this will give an increase dose force.Confirmed dose button may operate in jerks.Foreign dry matter observed on internal or external pen parts e.G.Dust, dirt or dried stains after a liquid.The observed problem is not related to any novo nordisk processes.The observed fault is a result of accidental damage during use of the device.Since last submission case was updated with the following: event verbatim updated to "it operates in jerks, the units are difficult to dial plus correct to dial, it is like a cogwheel" from "it operates in jerks" additional event of "use of dialling clicks to estimate the dose of the insulin" added onset date of events "severe hypoglycaemia", "hypoglycaemia and patient took 1 hour to get back to consciousness", ""pen is not delivering correct units" and "it operates in jerks, the units are difficult to dial plus correct to dial, it is like a cogwheel" was updated as oct-2018.Seriousness criteria of hospitalization added for the event of "severe hypoglycaemia" outcome for event of "severe hypoglycaemia" updated to "not yet recovered" device codes updated.Reporter's causality updated as probable for the events of "severe hypoglycaemia", "it operates in jerks, the units are difficult to dial plus correct to dial, it is like a cogwheel" and "pen is not delivering correct units".Action taken to novopen 4 updated as product discontinued due to ae and stop date updated as mar-2019.Indication of novopen 4 updated as "type 1 diabetes mellitus".Laboratory data updated.Patient's age, height, weight and body mass index updated.Novorapid added as concomitant medication.Investigation result updated.Manufacturer comment updated.Narrative updated accordingly.Manufacturer comment: 17-apr-2019: one suspected novopen 4 was returned to novo nordisk a/s for investigation.The investigation revealed that there was foreign matter inside the pen mechanism and under the dose button.The top of the dose button cannot rotate as normal this will give an increase dose force.Foreign dry matter observed on internal or external pen parts e.G.Dust, dirt or dried stains after a liquid.The observed problem is not related to any novo nordisk processes.The observed fault is a result of accidental damage during use of the device.Device evaluated by mfr: continued: evaluation summary: product: novopen 4.Batch number: aug1069.Visual and functional examinations were performed.The device was tested with a random cartridge and a novo nordisk needle was mounted.During testing it was possible to deliver preparation from the cartridge.The force required to depress the release-button was measured.The result was within acceptable limits.The dose accuracy was measured by weighing using a random penfill cartridge.The results were found to comply with specifications.The device was disassembled to examine internal parts.Foreign matter was observed inside the pen mechanism and under the dose button.The top of the dose button cannot rotate as normal this will give an increase dose force.Confirmed dose button may operate in jerks.Foreign dry matter observed on internal or external pen parts e.G.Dust, dirt or dried stains after a liquid.The observed problem is not related to any novo nordisk processes.The observed fault is a result of accidental damage during use of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVOPEN 4
Type of Device
INSULIN DELIVERY DEVICE
Manufacturer (Section D)
NOVO NORDISK A/S, MEDICAL SYSTEMS
hilleroed,
DA 
MDR Report Key8597036
MDR Text Key144672407
Report Number9681821-2019-00027
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
PMA/PMN Number
20-986
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Type of Report Initial,Followup
Report Date 03/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/09/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/01/2016
Device Model NumberN/A
Device Catalogue Number185490
Device Lot NumberAUG1069
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/20/2019
Date Manufacturer Received04/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
1) NOVORAPID (INSULIN ASPART)
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age30 YR
Patient Weight55
-
-